These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7694681

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM, Abboud MR, Laver J, Clapp DW, Srour EF.
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [Abstract] [Full Text] [Related]

  • 23. Retention and multilineage expression of human hematopoietic stem cells in human-sheep chimeras.
    Zanjani ED, Almeida-Porada G, Flake AW.
    Stem Cells; 1995 Mar; 13(2):101-11. PubMed ID: 7787777
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells.
    Huang S, Terstappen LW.
    Blood; 1994 Mar 15; 83(6):1515-26. PubMed ID: 7510144
    [Abstract] [Full Text] [Related]

  • 26. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential.
    Muench MO, Cupp J, Polakoff J, Roncarolo MG.
    Blood; 1994 Jun 01; 83(11):3170-81. PubMed ID: 7514903
    [Abstract] [Full Text] [Related]

  • 27. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
    Haas R, Möhle R, Pförsich M, Fruehauf S, Witt B, Goldschmidt H, Hunstein W.
    Blood; 1995 Apr 01; 85(7):1936-43. PubMed ID: 7535595
    [Abstract] [Full Text] [Related]

  • 28. Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor.
    Briddell RA, Broudy VC, Bruno E, Brandt JE, Srour EF, Hoffman R.
    Blood; 1992 Jun 15; 79(12):3159-67. PubMed ID: 1375842
    [Abstract] [Full Text] [Related]

  • 29. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S, Law P, Young D, Ho AD.
    Exp Hematol; 1998 Nov 15; 26(12):1162-71. PubMed ID: 9808056
    [Abstract] [Full Text] [Related]

  • 30. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF, Griffin JD, Kessler SW, Cutting MA, Knight RD, Blattler WA, Lambert JM, Wright DG.
    Exp Hematol; 1992 May 15; 20(4):442-8. PubMed ID: 1373688
    [Abstract] [Full Text] [Related]

  • 31. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM, Miller JS.
    Blood; 1994 Sep 01; 84(5):1442-9. PubMed ID: 7520771
    [Abstract] [Full Text] [Related]

  • 32. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.
    Verfaillie C, Blakolmer K, McGlave P.
    J Exp Med; 1990 Aug 01; 172(2):509-2. PubMed ID: 2373991
    [Abstract] [Full Text] [Related]

  • 33. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells.
    Brandt JE, Bhalla K, Hoffman R.
    Blood; 1994 Mar 15; 83(6):1507-14. PubMed ID: 7510143
    [Abstract] [Full Text] [Related]

  • 34. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development.
    Waller EK, Huang S, Terstappen L.
    Blood; 1995 Jul 15; 86(2):710-8. PubMed ID: 7541673
    [Abstract] [Full Text] [Related]

  • 35. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.
    Exp Hematol; 2000 Dec 15; 28(12):1470-80. PubMed ID: 11146169
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C, Delforge A, Bron D, Bernier M, Massy M, Ley P, de Hemptinne D, Stryckmans P.
    Stem Cells; 1995 May 15; 13(3):281-8. PubMed ID: 7613494
    [Abstract] [Full Text] [Related]

  • 37. In vivo haematopoietic potential of human neural stem cells.
    Almeida-Porada G, Crapnell K, Porada C, Benoit B, Nakauchi H, Quesenberry P, Zanjani ED.
    Br J Haematol; 2005 Jul 15; 130(2):276-83. PubMed ID: 16029457
    [Abstract] [Full Text] [Related]

  • 38. Role of c-kit ligand in the expansion of human hematopoietic progenitor cells.
    Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoffman R.
    Blood; 1992 Feb 01; 79(3):634-41. PubMed ID: 1370637
    [Abstract] [Full Text] [Related]

  • 39. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.
    Verstegen MM, van Hennik PB, Terpstra W, van den Bos C, Wielenga JJ, van Rooijen N, Ploemacher RE, Wagemaker G, Wognum AW.
    Blood; 1998 Mar 15; 91(6):1966-76. PubMed ID: 9490679
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT, Stockschläder M, Schleimer B, Krüger W, Zander AR.
    Transpl Immunol; 1996 Dec 15; 4(4):319-23. PubMed ID: 8972563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.